Table 1.
Comparisons of clinical characteristics, blood tests, echocardiography data, and medications between SCA and non‐SCA
| Variable | non‐SCA (n = 128) | SCA (n = 10) | p |
|---|---|---|---|
| Clinical characteristics | |||
| Male, n (%) | 109 (85.2) | 7 (70) | Ns |
| Age, years | 65 (57.2,74.7) | 79.5 (68.5,82.2) | .013 |
| Diabetes, n (%) | 32 (25.0) | 2 (20.0) | Ns |
| Hypertension, n (%) | 81 (63.3) | 5 (50.0) | Ns |
| Smoking, n (%) | 86 (67.2) | 3 (30.0) | .018 |
| Dyslipidemia, n (%) | 45 (35.4) | 3 (30.0) | Ns |
| Gensini score | 53.3 (36.2,82.9) | 86.0 (50.7,99.4) | Ns |
| Grace score | 137.2 (120.0,159.0) | 176.1 (127.2,186.2) | .035 |
| Blood tests | |||
| eGFR, ml/min/1.73 m2 | 93.5 (72.0,109.0) | 68.0 (32.5,99) | Ns |
| Uric acid, µM | 347.0 (272.0,413.5) | 392.0 (356.0,480.5) | Ns |
| Echocardiography | |||
| LAD, mm | 42.8 (38.0,46.7) | 41.5 (39.9,45.9) | Ns |
| LVDd, mm | 52.8 (49.0,55.8) | 51.5 (50.6,55.9) | Ns |
| LVDs, mm | 37 (31.0,41.7) | 38.0 (34.5,41.7) | Ns |
| LVEF, % | 55.0 (46.8,63.0) | 46.6 (43.0,62.0) | Ns |
| Pulmonary arterial pressure, mmHg | 30.0 (24.0,37.0) | 37.1 (26.7,41.2) | Ns |
| Medications | |||
| ACEI/ARB, n (%) | 79 (62.2) | 5 (50.0) | ns |
| β‐blockers, n (%) | 98 (77.2) | 6 (60.0) | ns |
| Asprin, n (%) | 122 (96.1) | 10 (100.0) | ns |
| Spironolactone, n (%) | 24 (18.9) | 0 (0.0) | ns |
Abbreviations: ACEI/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor antagonist; eGFR, estimated glomerular filtration rate; LAD, left atrial diameter; LVDd, left ventricular end‐diastolic dimension; LVDs, left ventricular end‐systolic dimension; LVEF, left ventricular ejection fraction.